Tech Company Financing Transactions

Marinus Pharmaceuticals Funding Round

Canaan Partners, Domain Associates and Flare Capital Partners joined a $21 million Series C funding round for Marinus Pharmaceuticals. The round was announced by the company on 12/18/2012.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

170 N. Radnor Chester Rd. 250
Radnor, PA 19087
USA

Phone

(484) 801-4670

Website

www.marinuspharma.com

Email Address

[email protected]

Overview

Marinus Pharmaceuticals (NASDAQ: MRNS) is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Scott Braunstein

        

Chief Financial Officer

Edward Smith

        

Chief Medical Officer

Joe Hulihan

        

VP - Bus. Development

Thomas Lyons

        

VP - Manufacturing

David Czekai

        

VP - Regulatory Affairs

Kimberly McCormick

        

Browse more venture capital transactions:

Prev: 12/18/2012: Grockit venture capital transaction
Next: 12/18/2012: Media Temple venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary